The binding of silibinin to ERp57

Chemico-Biological Interactions

Volumn 213, Issue 1, 2014, Pages 37-43

  Grillo, Caterina ^a   Chichiarelli, Silvia ^a   Gaucci, Elisa ^a   Altieri, Fabio ^a   Turano, Carlo ^a   Cervoni, Laura ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

ERp57; Protein ligand interaction; Ref1; Silibinin; STAT3

Indexed keywords

BACITRACIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN ERP57; QUERCETIN; RECOMBINANT PROTEIN; SILIBININ; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; COMPLEX FORMATION; DISSOCIATION CONSTANT; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ERP57; PROTEIN LIGAND INTERACTION; REF1; SILIBININ; STAT3;

CALORIMETRY; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; LIGANDS; PROTEIN BINDING; PROTEIN DISULFIDE-ISOMERASES; SILYMARIN;

EID: 84895169355     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.02.005     Document Type: Article

References (50)

1. A. Valenzuela, R. Guerra, and L.A. Videla Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene Planta Med. 6 1986 438 440
2. C. Loguercio, and D. Festi Silybin and the liver: from basic research to clinical practice World J. Gastroenterol. 17 2011 2288 2301
3. P. Ferenci, T.M. Scherzer, H. Kerschner, K. Rutter, S. Beinhardt, H. Hofer, M. Schöniger-Hekele, H. Holzmann, and P. Steindl-Munda Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy Gastroenterology 135 2008 1561 1567
4. A. Ahmed-Belkacem, N. Ahnou, L. Barbotte, C. Wychowski, C. Pallier, R. Brillet, R.T. Pohl, and J.M. Pawlotsky Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase Gastroenterology 138 2010 1112 1122
5. K. Flora, M. Hahn, H. Rosen, and K. Benner Milk thistle (Silybum marianum) for the therapy of liver disease Am. J. Gastroenterol. 93 1998 139 143
6. P. Ferenci, B. Dragosics, H. Dittrich, H. Frank, L. Benda, H. Lochs, S. Meryn, W. Base, and B. Schneider Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver J. Hepatol. 9 1989 105 113
7. K. Hruby, G. Csomos, M. Fuhrmann, and H. Thaler Chemotherapy of Amanita phalloides poisoning with intravenous silibinin Hum. Toxicol. 2 1983 183 195
8. F. Yin, J. Liu, X. Ji, Y. Wang, J. Zidichouski, and J. Zhang Silibinin: a novel inhibitor of Aβ aggregation J. Neurochem. Int. 58 2011 399 403
9. N. Bhatia, J. Zhao, D.M. Wolf, and R. Agarwal Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin Cancer Lett. 147 1999 77 84
10. K. Ramasamy, and R. Agarwal Multitargeted therapy of cancer by silymarin Cancer Lett. 269 2008 352 362
11. G. Deep, and R. Agarwal Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer Cancer Metastasis Rev. 29 2010 447 463
12. L. Li, J. Zeng, Y. Gao, and D. He Targeting silibinin in the antiproliferative pathway Expert Opin. Investig. Drugs 19 2010 243 255
13. H.J. Wang, Y.Y. Jiang, X.F. Wei, H. Huang, S. Tashiro, S. Onodera, and T. Ikejima Silibinin induces protective superoxide generation in human breast cancer MCF-7 cells Free Radic. Res. 44 2010 90 100
14. N. Ahmad, H. Gali, S. Javed, and R. Agarwal Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression Biochem. Biophys. Res. Commun. 247 1998 294 301
15. F. Teillet, A. Boumendjel, J. Boutonnat, and X. Ronot Flavonoids as RTK inhibitors and potential anticancer agents Med. Res. Rev. 28 2008 715 745
16. J.M. Pauff, and R. Hille Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin J. Nat. Prod. 72 2009 725 731
17. A. Innocenti, I. Gülçin, A. Scozzafava, and C.T. Supuran Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV Bioorg. Med. Chem. Lett. 20 2010 5050 5053
18. L. Skarydová, L. Zivná, G. Xiong, E. Maser, and V. Wsól AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids Chem. Biol. Interact. 178 2009 138 144
19. H. Zhao, G.E. Brandt, L. Galam, R.L. Matts, and B.S. Blagg Identification and initial SAR of silybin: an Hsp90 inhibitor Bioorg. Med. Chem. Lett. 21 2011 2659 2664
20. L. Trnkovà, D. Ricci, C. Grillo, G. Colotti, and F. Altieri Green tea catechins can bind and modify ERp57/PDIA3 activity Biochim. Biophys. Acta 2013 1830 2671 2682
21. D.M. Ferrari, and H.D. Söling The protein disulphide-isomerase family: unravelling a string of folds Biochem. J. 339 1999 1 10
22. R.B. Freedman, T.R. Hirst, and M.F. Tuite Protein disulphide isomerase: building bridges in protein folding Trends Biochem. Sci. 19 1994 331 336
23. J.D. Oliver, F.J. van der Wal, N.J. Bulleid, and S. High Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins Science 275 1997 86 88
24. M. Molinari, and A. Helenius Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells Nature 402 1999 90 93
25. J.A. Lindquist, O.N. Jensen, M. Mann, and G.J. Hämmerling ER-60, a chaperone with thiol-dependent reductase activity involved in MHC class I assembly EMBO J. 17 1998 2186 2195
26. C. Turano, S. Coppari, F. Altieri, and A. Ferraro Proteins of the PDI family: unpredicted non-ER locations and functions J. Cell. Physiol. 193 2002 154 163
27. C. Turano, E. Gaucci, C. Grillo, and S. Chichiarelli ERp57/GRP58: a protein with multiple functions Cell. Mol. Biol. Lett. 16 2011 539 563
28. C. Grillo, C. D'Ambrosio, A. Scaloni, M. Maceroni, S. Merluzzi, C. Turano, and F. Altieri Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors Free Radic. Biol. Med. 41 2006 1113 1123
29. C. Grillo, S. Coppari, C. Turano, and F. Altieri The DNA-binding activity of protein disulfide isomerase ERp57 is associated with the a(′) domain Biochem. Biophys. Res. Comm. 295 2002 67 73
30. E. Gaucci, S. Chichiarelli, C. Grillo, E. del Vecchio, M. Eufemi, and C. Turano The binding of antibiotics to Erp57/GRP58 J. Antibiot. (Tokyo) 61 2008 400 402
31. A.P. Heuck, and R.A. Wolosiuk Di-fluoresceinthiocarbamyl-insulin: a fluorescent substrate for the assay of protein disulfide oxidoreductase activity Anal. Biochem. 248 1997 94 101
32. L. Silvennoinen, J. Myllyharju, M. Ruoppolo, S. Orrù, M. Caterino, K.I. Kivirikko, and P. Koivunen Identification and characterization of structural domains of human ERp57: association with calreticulin requires several domains J. Biol. Chem. 279 2004 13607 13615
33. S. Coppari, F. Altieri, A. Ferraro, S. Chichiarelli, M. Eufemi, and C. Turano Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells J. Cell. Biochem. 85 2002 325 333
34. A.R. Karala, and L.W. Ruddock Bacitracin is not a specific inhibitor of protein disulfide isomerase FEBS J. 277 2010 2454 2462
35. M. Frasconi, S. Chichiarelli, E. Gaucci, F. Mazzei, C. Grillo, A. Chinazzi, and F. Altieri Interaction of ERp57 with calreticulin: analysis of complex formation and effects of vancomycin Biophys. Chem. 160 2012 46 53
36. 2D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells Proc. Natl. Acad. Sci. USA 101 2004 7392 7397
37. W. Wu, G. Beilhartz, Y. Roy, C.L. Richard, M. Curtin, L. Brown, D. Cadieux, M. Coppolino, M.C. Farach-Carson, I. Nemere, and K.A. Meckling Nuclear translocation of the 1,25D3-MARRS (membrane associated rapid response to steroids) receptor protein and NFkB in differentiating NB4 leukemia cells Exp. Cell Res. 316 2010 1101 1108
38. C. Dufour, and O. Dangles Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy Biochim. Biophys. Acta 1721 2005 164 173
39. O. Dangles, and C. Dufour Flavonoid-protein interactions ∅.M. Andersen, K.R. Markham, Flavonoids, Chemistry, Biochemistry and Applications 2006 CRC Press, Taylor & Francis Group Boca, Raton, FL, USA 443 469
40. S.J. Mah, A.M. Ades, R. Mir, I.R. Siemens, J.R. Williamson, and S.J. Fluharty Association of solubilized angiotensin II receptors with phospholipase C-α in murine neuroblastoma NIE-115 cells Mol. Pharmacol. 42 1992 217 226
41. N. Aiyar, C.F. Bennett, P. Nambi, W. Valinski, M. Angioli, M. Minnich, and S.T. Crooke Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C Biochem. J. 261 1989 63 70
42. E. Gaucci, F. Altieri, C. Turano, and S. Chichiarelli Protein ERp57 contributes to EGF receptor signaling and internalization in MDA-MB-468 breast cancer cells J. Cell. Biochem 2013
43. C. Agarwal, A. Tyagi, M. Kaur, and R. Agarwal Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells Carcinogenesis 28 2007 1463 1470
44. G.G. Guo, K. Patel, V. Kumar, M. Shah, V.A. Fried, J.D. Etlinger, and P.B. Sehgal Association of the chaperone glucose-regulated protein 58 (GRP58/ER-60/ERp57) with Stat3 in cytosol and plasma membrane complexes J. Interferon Cytokine Res. 22 2002 555 563
45. M.I. Ndubuisi, G.G. Guo, V.A. Fried, J.D. Etlinger, and P.B. Sehgal Cellular physiology of STAT3: where's the cytoplasmic monomer? J. Biol. Chem. 274 1999 25499 25509
46. M. Eufemi, S. Coppari, F. Altieri, C. Grillo, A. Ferraro, and C. Turano ERp57 is present in STAT3-DNA complexes Biochem. Biophys. Res. Commun. 323 2004 1306 1312
47. S. Chichiarelli, E. Gaucci, A. Ferraro, C. Grillo, F. Altieri, R. Cocchiola, V. Arcangeli, C. Turano, and M. Eufemi Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line Arch. Biochem. Biophys. 494 2010 178 183
48. K. Raina, C. Agarwal, and R. Agarwal Effect of silibinin in human colorectal cancer cells: targeting the activation of NF-κB signaling Mol. Carcinog. 52 2013 195 206
49. Y. Sharma, C. Agarwal, A.K. Singh, and R. Agarwal Inhibitory effect of silibinin on ligand binding to erbB1 and associated mitogenic signaling, growth, and DNA synthesis in advanced human prostate carcinoma cells Mol. Carcinog. 30 2001 224 236
50. L. Qi, R.P. Singh, Y. Lu, R. Agarwal, G.S. Harrison, A. Franzusoff, and L.M. Glode Epidermal growth factor receptor mediates silibinin-induced cytotoxicity in a rat glioma cell line Cancer Biol. Ther. 2 2003 526 531